Relationships among the concentrations of 25 inflammation-associated proteins during the first postnatal weeks in the blood of infants born before the 28th week of gestation

Cytokine

Volumn 57, Issue 1, 2012, Pages 182-190

  Leviton, Alan ^a   Allred, Elizabeth N ^a,b   Yamamoto, Hidemi ^c   Fichorova, Raina N ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Biomarkers; Inflammation; Preterm newborn

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; CXCL11 CHEMOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 3; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 4; MYELOPEROXIDASE; RANTES; SERUM AMYLOID A; SOMATOMEDIN BINDING PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ARTICLE; BLOOD ANALYSIS; CHEMOLUMINESCENCE; CONCENTRATION (PARAMETERS); EXPLORATORY RESEARCH; EXTREMELY LOW BIRTH WEIGHT; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; NEWBORN; PERINATAL PERIOD; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS;

BLOOD PROTEINS; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFLAMMATION;

EID: 84155160664     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.11.004     Document Type: Article

References (48)

1. Bose C., Laughon M., Allred E.N., Van Marter L.J., O'Shea T.M., Ehrenkranz R.A., et al. Blood protein concentrations in the first two postnatal weeks that predict bronchopulmonary dysplasia among infants born before the 28th week of gestation. Pediatr Res 2011, 69:347-353.
2. Dammann O., O'Shea T.M. Cytokines and perinatal brain damage. Clin Perinatol 2008, 35:643-663.
3. Hansen-Pupp I., Hallin A.L., Hellstrom-Westas L., Cilio C., Berg A.C., Stjernqvist K., et al. Inflammation at birth is associated with subnormal development in very preterm infants. Pediatr Res 2008, 64:183-188.
4. Leviton A., Kuban K., Allred E.N., Fichorova R., O'Shea T.M., Paneth N. Elevated concentrations of circulating indicators of inflammation in infants born before the 28th post-menstrual week predict a small head circumference two years later. Early Hum Dev 2011, 87:325-330.
5. Leviton A., Kuban K., O'Shea T.M., Paneth N., Fichorova R., Allred E.N., et al. The relationship between early concentrations of 25 blood proteins and cerebral white matter injury in preterm newborns: The ELGAN Study. J Pediatr 2011, 158:897-903. [e1-5].
6. O'Shea TM, Allred EN, Kuban K, Dammann O, Paneth N, Fichorova R, et al. Elevated concentrations of inflammation-related proteins in postnatal blood predict severe developmental delay at two years in extremely premature infants. J Pediatr 2011 [Epub ahead of print].
7. Cai Z., Lin S., Pang Y., Rhodes P.G. Brain injury induced by intracerebral injection of interleukin-1beta and tumor necrosis factor-alpha in the neonatal rat. Pediatr Res 2004, 56:377-384.
8. Girard S., Tremblay L., Lepage M., Sebire G. IL-1 receptor antagonist protects against placental and neurodevelopmental defects induced by maternal inflammation. J Immunol 2010, 184:3997-4005.
9. Wang K.C., Wang S.J., Fan L.W., Cai Z., Rhodes P.G., Tien L.T. Interleukin-1 receptor antagonist ameliorates neonatal lipopolysaccharide-induced long-lasting hyperalgesia in the adult rats. Toxicology 2011, 279:123-129.
10. Wang H., Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med 2008, 26:711-715.
11. Matoba N., Yu Y., Mestan K., Pearson C., Ortiz K., Porta N., et al. Differential patterns of 27 cord blood immune biomarkers across gestational age. Pediatrics 2009, 123:1320-1328.
12. Calvano S.E., Xiao W., Richards D.R., Felciano R.M., Baker H.V., Cho R.J., et al. A network-based analysis of systemic inflammation in humans. Nature 2005, 437:1032-1037.
13. Nesbitt A., Fossati G., Bergin M., Stephens P., Stephens S., Foulkes R., et al. Mechanism of action of certolizumab pegol (CDP870): in vitro comparison with other anti-tumor necrosis factor alpha agents. Inflamm Bowel Dis 2007, 13:1323-1332.
14. Macdonald T.T. Inside the microbial and immune labyrinth: totally gutted. Nat Med 2010, 16:1194-1195.
15. O'Shea T.M., Allred E.N., Dammann O., Hirtz D., Kuban K.C., Paneth N., et al. The ELGAN study of the brain and related disorders in extremely low gestational age newborns. Early Hum Dev 2009, 85:719-725.
16. Fichorova R.N., Trifonova R.T., Gilbert R.O., Costello C.E., Hayes G.R., Lucas J.J., et al. Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infect Immun 2006, 74:5773-5779.
17. Fichorova R.N., Richardson-Harman N., Alfano M., Belec L., Carbonneil C., Chen S., et al. Biological and technical variables affecting immunoassay recovery of cytokines from human serum and simulated vaginal fluid: a multicenter study. Anal Chem 2008, 80:4741-4751.
18. Fichorova R.N., Onderdonk A., Yamamoto H., Delaney M.L., Dubois A.M., Allred E.N., et al. Extremely Low Gestational Age Newborns (ELGAN) Study Investigators. Maternal microbe-specific modulation of inflammatory response in extremely low-gestational-age newborns. mBio 2011, 2:e00280-e00310.
19. Hecht J.L., Fichorova R.N., Tang V.F., Allred E., McElrath T.F., Leviton A. The relationship between neonatal blood protein profiles and placenta histologic characteristics in ELGANs. Pediatr Res 2011, 69:68-73.
20. McElrath T.F., Fichorova R.N., Allred E.N., Hecht J.L., Ismail M.A., Yuan H., et al. Blood protein profiles of infants born before 28th weeks differ by pregnancy complication. Am J Obstet Gynecol 2011.
21. Leviton A., Fichorova R., Yamamoto Y., Allred E.N., Dammann O., Hecht J., et al. Inflammation-related proteins in the blood of extremely low gestational age newborns. The contribution of inflammation to the appearance of developmental regulation. Cytokine 2011, 53:66-73.
22. Wilson E.H., Weninger W., Hunter C.A. Trafficking of immune cells in the central nervous system. J Clin Invest 2010, 120:1368-1379.
23. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
24. Dammann O., Durum S., Leviton A. Do white cells matter in white matter damage?. Trends Neurosci 2001, 24:320-324.
25. Popovich P.G., Longbrake E.E. Can the immune system be harnessed to repair the CNS?. Nat Rev Neurosci 2008, 9:481-493.
26. Patel S., Dammann O., Martin C.R., Allred E.N., Leviton A. Presumed and definite bacteremia in extremely low gestational age newborns. Acta Paediatr 2011, 100:36-41. for the ESI.
27. Beutler B.A., Milsark I.W., Cerami A. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J Immunol 1985, 135:3972-3977.
28. Klapproth J., Castell J., Geiger T., Andus T., Heinrich P.C. Fate and biological action of human recombinant interleukin 1 beta in the rat in vivo. Eur J Immunol 1989, 19:1485-1490.
29. Castell J.V., Geiger T., Gross V., Andus T., Walter E., Hirano T., et al. Plasma clearance, organ distribution and target cells of interleukin-6/hepatocyte-stimulating factor in the rat. Eur J Biochem 1988, 177:357-361.
30. Ridker P.M. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003, 107:363-369.
31. Leviton A., Dammann O., Durum S.K. The adaptive immune response in neonatal cerebral white matter damage. Ann Neurol 2005, 58:821-828.
32. Theofilopoulos A.N., Gonzalez-Quintial R., Lawson B.R., Koh Y.T., Stern M.E., Kono D.H., et al. Sensors of the innate immune system: their link to rheumatic diseases. Nat Rev Rheumatol 2010, 6:146-156.
33. Snegovskikh V.V., Schatz F., Arcuri F., Toti P., Kayisli U.A., Murk W., et al. Intra-amniotic infection upregulates decidual cell vascular endothelial growth factor (VEGF) and neuropilin-1 and -2 expression: implications for infection-related preterm birth. Reprod Sci 2009, 16:767-780.
34. Kemp M.W., Saito M., Newnham J.P., Nitsos I., Okamura K., Kallapur S.G. Preterm birth, infection, and inflammation advances from the study of animal models. Reprod Sci 2010, 17:619-628.
35. Colombo C., Faelli N., Tirelli A.S., Fortunato F., Biffi A., Claut L., et al. Analysis of inflammatory and immune response biomarkers in sputum and exhaled breath condensate by a multi-parametric biochip array in cystic fibrosis. Int J Immunopathol Pharmacol 2011, 24:423-432.
36. Liu Y., Han Z.P., Zhang S.S., Jing Y.Y., Bu X.X., Wang C.Y., et al. Effects of inflammatory factors on mesenchymal stem cells and their role in the promotion of tumor angiogenesis in colon cancer. J Biol Chem 2011, 286:25007-25015.
37. Keating S.M., Golub E.T., Nowicki M., Young M., Anastos K., Crystal H., et al. The effect of HIV infection and HAART on inflammatory biomarkers in a population-based cohort of US women. AIDS 2011.
38. Luo J., Xiong Y., Han X., Lu Y. VEGF non-angiogenic functions in adult organ homeostasis: therapeutic implications. J Mol Med (Berl) 2011, 89:635-645.
39. Saban M.R., Hellmich H., Nguyen N.B., Winston J., Hammond T.G., Saban R. Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation. Physiol Genomics 2001, 5:147-160.
40. Saban R., Saban M.R., Maier J., Fowler B., Tengowski M., Davis C.A., et al. Urothelial expression of neuropilins and VEGF receptors in control and interstitial cystitis patients. Am J Physiol Renal Physiol 2008, 295:F1613-23.
41. Buhimschi C.S., Bhandari V., Han Y.W., Dulay A.T., Baumbusch M.A., Madri J.A., et al. Using proteomics in perinatal and neonatal sepsis: hopes and challenges for the future. Curr Opin Infect Dis 2009, 22:235-243.
42. Frost R.A., Lang C.H. Alteration of somatotropic function by proinflammatory cytokines. J Anim Sci 2004, 82(E-Suppl.):E100-E109.
43. Laughon M., Bose C., Allred E.N., O'Shea T.M., Ehrenkranz R.A., Van Marter L.J., et al. Patterns of blood protein concentrations of ELGANs classified by three patterns of respiratory disease in the first two postnatal weeks. Pediatr Res 2011.
44. Arnold C.C., Kramer M.S., Hobbs C.A., McLean F.H., Usher R.H. Very low birth weight: a problematic cohort for epidemiologic studies of very small or immature neonates. Am J Epidemiol 1991, 134:604-613.
45. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1990, 1:43-46.
46. Savitz D.A., Olshan A.F. Multiple comparisons and related issues in the interpretation of epidemiologic data. Am J Epidemiol 1995, 142:904-908.
47. Perneger T.V. What's wrong with Bonferroni adjustments. BMJ 1998, 316:1236-1238.
48. Feise R.J. Do multiple outcome measures require p-value adjustment?. BMC Med Res Methodol 2002, 2:8.